Myeloma Video Channel
Explore the latest insights and summaries from experts in Myeloma.
Treatment Landscape
University of Colorado Division of Hematology
Multiple Myeloma: Initial Treatment Approaches
FEATURING
Alex Hirose
- 69 views
- October 22, 2024
- 2
Cleveland Clinic Taussig Cancer Institute
Updates in Plasma Cell Disorders From ASH 2023
FEATURING
Jack Khouri
- 17 views
- October 22, 2024
University of Colorado Division of Hematology
The Future of Multiple Myeloma: SCT, CAR-T, and BiTE Therapy
FEATURING
Kelly Sidor
- 78 views
- October 23, 2024
- 1
Dana-Farber Cancer Institute
FDA Approval of Isatuximab in 1L MM: Perspectives for Practice
FEATURING
Paul Richardson
- 550 views
- November 12, 2024
- 7
Yale Cancer Center
Multiple Myeloma: Hot Topics in 2024
FEATURING
Sabrina Browning
- 193 views
- October 21, 2024
- 3
Springer Healthcare IME
Anti-BCMA ADCs - Independent Symposium at the 10th World Congress on Controversies in Multiple Myeloma (COMy)
FEATURING
Rakesh Popat
- 60 views
- October 30, 2024
- 1
Saurabh Chhabra
Len/Dara vs. Len Maintenance in NDMM: Comparing DRAMMATIC, PERSEUS, and AURIGA Ph3 Studies
- 87 views
- November 3, 2024
- 1
MyCancerHaven
Experts Discuss How They Sequence MM Therapies
FEATURING
Ravi Vij,
Rachid Baz
- 103 views
- May 24, 2024
Moffitt Cancer Center
CAR T-Cell Therapies for Pts With R/R Myeloma: Updates From the Real World
FEATURING
Doris Hansen
- 245 views
- May 24, 2024
- 1
Dana-Farber Cancer Institute
Continued Evolution of Therapy for Patients With Newly Diagnosed MM
FEATURING
Clifton Mo
- 144 views
- June 10, 2024
- 2
Memorial Sloan Kettering Cancer Center
ASTCT Survey on Management of R/R Myeloma Patients After Failure by CAR-T
FEATURING
Hamza Hashmi
- 142 views
- May 21, 2024
- 1
MyCancerHaven
Will CAR-Ts and Bispecifics Replace HSCT in Myeloma?
FEATURING
Ravi Vij,
Samer Al Hadidi
- 625 views
- May 23, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Quadruplets in NDMM - The More the Better?"
FEATURING
Ola Landgren
- 417 views
- June 12, 2024
- 7
ecancer
ASCO® 2024 Summary: "IMROZ & BENEFIT Studies in Newly Diagnosed Myeloma"
FEATURING
Xavier Leleu
- 187 views
- June 24, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Sequencing Immunotherapy for Myeloma"
FEATURING
Samir Parekh
- 245 views
- June 25, 2024
- 4
Insights from 2024 EHA Annual Meeting
Highlights in Plasma Cell Disorders From ASCO® and EHA
FEATURING
Samer Al Hadidi
- 474 views
- June 27, 2024
- 7
Rush University Medical Center
High-Risk Myeloma: Updates in Defining and Managing
FEATURING
Jeffrey Zonder
- 133 views
- June 6, 2024
Rush University Medical Center
CAR-T vs. Bispecific Antibodies in R/R MM: Insights and Future Directions
FEATURING
Attaya Suvannasankha
- 197 views
- June 14, 2024
- 2
Rush University Medical Center
The Role of SCT Amidst Emerging Therapies in the Treatment of AL Amyloidosis
FEATURING
Vaishali Sanchorawala
- 37 views
- June 14, 2024
- 1
Total Health
Hematologic Malignancies Update: Treatment Strategies for AML, DLBCL, MM, and CLL
FEATURING
Marcello Maria Rotta
- 240 views
- July 8, 2024
Dana-Farber Cancer Institute
Advances in Multiple Myeloma 2024: From Bench to Bedside
FEATURING
Kenneth Anderson
- 651 views
- July 1, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 Abstracts"
FEATURING
Hamza Hashmi
- 625 views
- July 1, 2024
- 5
Integrity CE
Treatment Strategies for R/R MM After Frontline Anti-CD38 Therapy
FEATURING
Saad Usmani,
Jens Hillengass
- 218 views
- August 13, 2024
- 2
SOHO Brazil 2024
Frontline MM: Are Four Better Than Three?
FEATURING
Noopur S. Raje
- 79 views
- July 11, 2024
- 1
SOHO Brazil 2024
When to Consider Bispecific and CAR-T Therapy in MM
FEATURING
Noopur S. Raje
- 411 views
- July 11, 2024
- 5
ecancer
EHA 2024 Summary: Highlights of Key Studies in Multiple Myeloma
FEATURING
Claudio Cerchione
- 112 views
- July 23, 2024
2024 ASCO® Annual Meeting Insights Hub
Highlights of Recent Updates in Myeloma: Part 2 - R/R Treatment
FEATURING
Andrzej Jakubowiak
- 260 views
- July 31, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
Highlights of Recent Updates in Myeloma: Part 1 - Frontline Treatment
FEATURING
Andrzej Jakubowiak
- 310 views
- July 31, 2024
- 3
UCSF School of Medicine
Best of ASCO® 2024: Myeloma Highlights and Practice Impacts
FEATURING
Ajai Chari
- 183 views
- August 7, 2024
- 2
Integrity CE
Current Updates in the Management of NDMM
FEATURING
Jens Hillengass,
Saad Usmani
- 82 views
- August 15, 2024
MyCancerHaven
DreaMM-7 and DreaMM-8: Ready for the Return of Belamaf in Myeloma?
FEATURING
Ravi Vij,
Ajai Chari
- 129 views
- September 3, 2024
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Best of ASCO® 2024: Myeloma
FEATURING
Jennifer Cooperrider
- 87 views
- September 4, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Sequencing Immunotherapies and CAR-T Application in Multiple Myeloma
FEATURING
Claudio Cerchione
- 38 views
- September 6, 2024
UNC Lineberger Comprehensive Cancer Center
Updates on the Management of Later Relapses of Multiple Myeloma
FEATURING
Samuel Rubinstein
- 80 views
- September 16, 2024
UNC Lineberger Comprehensive Cancer Center
Updates on the Management of Early Relapsed Multiple Myeloma
FEATURING
Samuel Rubinstein
- 45 views
- September 16, 2024
UNC Lineberger Comprehensive Cancer Center
Updates on the Management of 1L Multiple Myeloma
FEATURING
Samuel Rubinstein
- 79 views
- September 16, 2024
- 1
Dana-Farber Cancer Institute
Updates on AL Amyloidosis Treatment: What’s New in 2024
FEATURING
Giada Bianchi
- 180 views
- July 2, 2024
Meral Beksaç
Post ASCO®/EHA 2024 Treatment of Transplant Ineligible Myeloma Patients
- 39 views
- July 22, 2024
Nebraska Oncology Society
Updates on Advances in the Treatment R/R Myeloma
FEATURING
Ravi Vij
- 78 views
- August 1, 2024
Nebraska Oncology Society
Updates on Advances in the Treatment of Newly Diagnosed Myeloma
FEATURING
Ravi Vij
- 88 views
- August 1, 2024
- 2
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Treatment of 1L Myeloma in 2024
FEATURING
Ahmad Ibrahim
- 34 views
- August 26, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Comprehensive Review of 1L Therapy Approaches in MM
FEATURING
Alpay Yeşilaltay
- 11 views
- August 26, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Treatment Strategies for R/R Multiple Myeloma
FEATURING
Claudio Cerchione
- 30 views
- September 6, 2024
Houston Methodist
Multiple Myeloma: A Journey From Pharaoh's Times to 2024
FEATURING
Siddhartha Ganguly
- 179 views
- September 10, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in Heme Malignancies
FEATURING
Maria Gomes da Silva
- 467 views
- September 23, 2024
- 2
COR2ED The Heart of Medical Education
Current Best Practices in Treating Early R/R MM
FEATURING
Joseph Mikhael
- 14 views
- October 1, 2024
COR2ED The Heart of Medical Education
Unmet Medical Needs in Early MM Relapse
FEATURING
Elena Zamagni
- 27 views
- October 1, 2024
Fredrik Schjesvold
Decision Making Post-ASCT in Myeloma - Data Supporting Strategies
- 13 views
- October 8, 2024
Scripps Health
AL Amyloidosis: Current and Emerging Treatments
FEATURING
David Oveisi
- 11 views
- November 4, 2024
Indy Hematology Review
Multiple Myeloma: Understanding Your Immune Effector Therapeutic Options
FEATURING
Saad Usmani
- 230 views
- April 18, 2024
- 2
Indy Hematology Review
Managing Amyloidosis in 2024: Diagnosis and Treatment
FEATURING
Morie Gertz
- 968 views
- April 23, 2024
- 8
Indy Hematology Review
2024 Updates on Understanding & Managing Immune Effector Cell Toxicities in Hematologic Malignancies
FEATURING
David Reeves
- 243 views
- April 30, 2024
- 2
Oncology Data Advisor
Multiple Myeloma Awareness Month: What Patients Need to Know
- 17 views
- May 6, 2024
University of Colorado Division of Hematology
2024 Updates on Multiple Myeloma Treatment
FEATURING
Daniel Sherbenou
- 436 views
- April 11, 2024
- 1
Saurabh Chhabra
Bispecifics & CAR-Ts in MM: How to Choose and How to Sequence
- 383 views
- April 19, 2024
- 2
MyCancerHaven
Multiple Myeloma: Experts Discuss How to Choose Between CAR-Ts and Bispecifics
FEATURING
Ravi Vij,
Nitya Nathwani
- 261 views
- May 2, 2024
- 2
Memorial Sloan Kettering Cancer Center
Key Myeloma & MGUS Updates From ASH
FEATURING
Sham Mailankody
- 327 views
- May 2, 2024
- 2
Indy Hematology Review
Managing Newly Diagnosed MM in 2024
FEATURING
Saad Usmani
- 691 views
- May 2, 2024
- 5
MyCancerHaven
Treating Amyloidosis in 2024
FEATURING
Ravi Vij,
Jeffrey Zonder
- 162 views
- May 9, 2024
- 1
MyCancerHaven
The Influence of PERSEUS and IsKia Trials on Frontline Therapy Choices in MM
FEATURING
Ravi Vij,
Thomas Martin
- 91 views
- May 13, 2024
- 2
Yale Cancer Center
Frontline Treatment Strategies in MM: A Comprehensive Overview of Clinical Trials and Real-World Data
FEATURING
Terri Parker
- 118 views
- May 14, 2024
- 1
Moffitt Cancer Center
Multiple Myeloma: What You Need to Know About New FDA Approvals of CAR-Ts in Earlier Lines
FEATURING
Doris Hansen
- 378 views
- April 15, 2024
- 2
Indy Hematology Review
2024 Updates on Emerging & Current Treatment of Multiple Myeloma
FEATURING
Kenneth Anderson
- 1,225 views
- April 16, 2024
- 5
City of Hope
Sequencing T-Cell Therapies in Relapsed Myeloma: BCMA, Bispecifics, and Resistance
FEATURING
Amrita Krishnan
- 56 views
- November 21, 2024
Winship Cancer Institute - Emory University
Triplets vs. Quadruplets: What Is the Right Approach for NDMM?
FEATURING
Nisha Joseph
- 32 views
- November 25, 2024
Total Health
Fast Five Key Updates in Malignant Heme: Pearls From a Pharmacist
FEATURING
Sarah Medeiros
- 126 views
- November 26, 2024
- 2
COR2ED The Heart of Medical Education
The Relevance of Adding a New Mechanism of Action in R/R MM
FEATURING
Fredrik Schjesvold
- 12 views
- October 1, 2024
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
2024 Updates in MM: The Role of Immunotherapy
FEATURING
Adam D. Cohen
- 291 views
- March 1, 2024
- 4
Moffitt Cancer Center
Hot Off the Press: Experts Discuss the Latest Data in Plasma Cell Dyscrasias
- 117 views
- March 6, 2024
Moffitt Cancer Center
Newly Diagnosed Myeloma: Why We Should NOT Use a Response-Adapted Approach to Transplant
FEATURING
Omar Castañeda-Puglianini
- 192 views
- March 11, 2024
- 1
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Managing Newly Diagnosed Myeloma in 2024
FEATURING
Alfred Garfall
- 428 views
- March 11, 2024
- 1
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Approaches to Preventing and Treating GVHD in 2024
FEATURING
Nasheed Hossain
- 137 views
- March 11, 2024
- 2
GRACE
Oncologists' Guidance on Treating Smoldering Myeloma: Panel Discussion
- 133 views
- March 15, 2024
UChicago Medicine
Multiple Myeloma: CAR T-Cells and Bispecifics - A Case for Moving Them Early
FEATURING
Noopur Raje
- 257 views
- March 18, 2024
- 1
UChicago Medicine
Practice-Changing and Promising New Treatments in Myeloma
FEATURING
Ben Derman
- 135 views
- March 19, 2024
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: Multiple Myeloma
FEATURING
Sagar Lonial
- 307 views
- March 25, 2024
Scripps Health
Should Patients With High-Risk SMM Be Treated Outside a Clinical Trial? No
FEATURING
Morie Gertz
- 528 views
- March 29, 2024
- 5
Samer Al Hadidi
CAR-Ts Earlier in MyelomaTherapy?: What We Learned From the Recent FDA ODAC Meeting
- 606 views
- March 29, 2024
- 3
Shaji Kumar
Indefinite Treatment of Multiple Myeloma: Strategies for Frail Patients
- 87 views
- December 10, 2024
- 3
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: Ide-Cel in NDMM With Inadequate Response to 1L ASCT - KarMMa-2 Trial Follow-Up
FEATURING
Barry Paul
- 3 views
- December 17, 2024
